Total Payments
$2,216
2024 Payments
$135.93
Companies
18
Transactions
40
Medicare Patients
1,273
Medicare Billing
$561,102
Payment Breakdown by Category
Consulting$1,186 (53.5%)
Food & Beverage$745.99 (33.7%)
Education$283.94 (12.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,186 | 3 | 53.5% |
| Food and Beverage | $745.99 | 34 | 33.7% |
| Education | $283.94 | 3 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $936.00 | 2 | $0 (2022) |
| Incyte Corporation | $283.94 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $256.38 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $250.00 | 1 | $0 (2021) |
| PFIZER INC. | $118.38 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $59.72 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $57.66 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $44.92 | 3 | $0 (2022) |
| Lilly USA, LLC | $36.93 | 2 | $0 (2022) |
| BeiGene USA, Inc. | $25.72 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.93 | 4 | Incyte Corporation ($84.99) |
| 2023 | $163.94 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($121.72) |
| 2022 | $1,121 | 25 | Celgene Corporation ($572.00) |
| 2021 | $795.11 | 7 | Celgene Corporation ($364.00) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/03/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 03/18/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $84.99 | General |
| 01/10/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Oncology | ||||||
| 12/07/2023 | PFIZER INC. | BOSULIF (Drug), ELREXFIO | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/01/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Hematology | ||||||
| 06/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $121.72 | General |
| 05/25/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/15/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Oncology | ||||||
| 09/14/2022 | PFIZER INC. | BOSULIF (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/13/2022 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Oncology | ||||||
| 09/13/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Oncology | ||||||
| 09/07/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 09/06/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 08/25/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2022 | Sobi, Inc | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/11/2022 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Oncology | ||||||
| 08/09/2022 | PFIZER INC. | BOSULIF (Drug), BESPONSA, PAXLOVID | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/08/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $111.05 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2022 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Oncology | ||||||
| 07/22/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Oncology | ||||||
| 07/21/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 938 | 51,165 | $1.3M | $536,585 |
| 2022 | 14 | 335 | 1,377 | $109,744 | $24,517 |
Total Patients
1,273
Total Services
52,542
Medicare Billing
$561,102
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 16 | 12,600 | $441,000 | $216,724 | 49.1% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 11 | 3,600 | $316,800 | $155,425 | 49.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 2,580 | $82,560 | $48,002 | 58.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 13 | 980 | $74,480 | $25,976 | 34.9% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 16 | 300 | $86,880 | $22,896 | 26.4% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 15 | 15,000 | $30,000 | $13,262 | 44.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 61 | 118 | $70,446 | $11,901 | 16.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 142 | 251 | $60,240 | $10,922 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 77 | $28,182 | $10,110 | 35.9% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 14 | 2,860 | $11,440 | $3,900 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 29 | $7,946 | $2,691 | 33.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 49 | 194 | $19,982 | $2,240 | 11.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 15 | 15 | $14,820 | $1,900 | 12.8% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 26 | 9,900 | $9,900 | $1,605 | 16.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 65 | 164 | $11,808 | $1,553 | 13.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 44 | 219 | $14,235 | $1,240 | 8.7% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 15 | 24 | $6,960 | $1,215 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 95 | $1,425 | $798.00 | 56.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 34 | 73 | $2,920 | $755.55 | 25.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 37 | 79 | $2,528 | $601.19 | 23.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 26 | $3,406 | $546.25 | 16.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 22 | 40 | $4,440 | $499.32 | 11.2% |
| 96377 | Application of on-body injector for under skin injection | Office | 2023 | 14 | 22 | $1,936 | $312.18 | 16.1% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 20 | 400 | $2,800 | $307.14 | 11.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 19 | $1,064 | $253.84 | 23.9% |
About Ayelet Nelson, NP
Ayelet Nelson, NP is a Social Worker healthcare provider based in Clifton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1235362120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ayelet Nelson, NP has received a total of $2,216 in payments from pharmaceutical and medical device companies, with $135.93 received in 2024. These payments were reported across 40 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($1,186).
As a Medicare-enrolled provider, Nelson has provided services to 1,273 Medicare beneficiaries, totaling 52,542 services with total Medicare billing of $561,102. Data is available for 2 years (2022–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Social Worker
- Other Specialties Adult Health, Adult Health
- Location Clifton, NJ
- Active Since 08/26/2009
- Last Updated 04/25/2022
- Taxonomy Code 104100000X
- Entity Type Individual
- NPI Number 1235362120
Products in Payments
- ONUREG (Drug) $364.00
- CARVYKTI (Drug) $250.00
- BOSULIF (Drug) $118.38
- NINLARO (Drug) $111.05
- KEYTRUDA (Biological) $57.66
- CYRAMZA (Drug) $36.93
- IMBRUVICA (Drug) $29.39
- BRUKINSA (Drug) $25.72
- SANCUSO (Drug) $24.49
- ICLUSIG (Drug) $23.61
- VENCLEXTA (Drug) $21.53
- Lonsurf (Drug) $19.09
- DOPTELET (Drug) $18.69
- Tivdak (Drug) $18.42
- PROMACTA (Drug) $16.93
- clonoSEQ (Device) $16.36
- ERLEADA (Drug) $15.74
- SCEMBLIX (Drug) $15.09
- DARZALEX (Biological) $14.59
- INJECTAFER (Drug) $14.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Social Worker Doctors in Clifton
Ms. Staela Keegan, Lsw, LSW
Social Worker
Social Worker
Jaclyn Bauer, Msw, Lcsw, MSW, LCSW
Social Worker
Social Worker
Catherine Inchaustegui
Social Worker
Social Worker
Mrs. Sara Walles, Lcsw, LCSW
Social Worker
Social Worker
Yohanny Sisco
Social Worker
Social Worker
Ginamarie Ramirez, L.s.w, L.S.W
Social Worker
Social Worker